Skip to main content
. 2006 Mar 28;12(12):1849–1858. doi: 10.3748/wjg.v12.i12.1849

Table 6.

Anemia and hemoglobin increase versus decrease during radiotherapy (subgroup analysis of 199 patients with documented hemoglobin values before and after radiotherapy)

OAS (%) CSS (%) DFS(%) LRS (%) DRS (%)
Anemia before RCT
No 5 yr / 10 yr: 44.6 / 31.4 66.4 / 66.4 41.5 / 33.7 76.6 / 76.6 74.9 / 74.9
Yes 5 yr / 10 yr: 49.5 / 47.2 55.4 / 45.6 48.5 / 39.2 61.5 / 59.6 88.1 / 88.1
uni- / multivariate: P = 0.39 / NS 0.14 / NS 0.83 / 0.04 0.04 / NS 0.01 / NS
multivariate risk ratio: anemia present: 0.76
(CI 0.57 – 0.99)
Anemia after RCT
No 5 yr / 10 yr: 47.5 / 34.0 57.4 / 48.4 42.5 / 34.7 87.6 / 87.6 62.7 / 60.7
Yes 5 yr / 10 yr: 47.0 / 41.5 64.7 / 59.3 39.6 / 35.9 80.0 / 80.0 73.0 / 73.0
uni- / multivariate: P = 0.76 / NS 0.56 / NS 0.83 / NS 0.12 / NS 0.06 / NS
multivariate risk ratio:
Hemoglobin (Hb) increase or decrease during RT
Hb increase 5 yr / 10 yr: 67.7 / 59.3 58.8 / 51.4 45.2 / 45.2 83.8 / 83.8 62.8 / 62.8
Hb decrease 5 yr / 10 yr: 35.3 / 35.3 38.7 / 33.9 36.2 / 36.2 73.9 / 73.9 75.9 / 75.9
uni- / multivariate: P = < 0.01 / NS < 0.01 / NS 0.08 / 0.04 0.38 / NS 0.79 / NS
multivariate risk ratio: Hb decrease: 1.97
(CI 1.02 – 3.43)

Survival rates and results of the uni- and multivariate analysis as well as risk ratio with confidence interval (CI) are given if multivariate analysis (step down analysis) revealed a significant result. Five- and 10-year survival rates are given as OAS, CSS, DFS, LRS and DRS